A DNA replication mechanism for generating nonrecurrent rearrangements associated with genomic disorders
- PMID: 18160035
- DOI: 10.1016/j.cell.2007.11.037
A DNA replication mechanism for generating nonrecurrent rearrangements associated with genomic disorders
Abstract
The prevailing mechanism for recurrent and some nonrecurrent rearrangements causing genomic disorders is nonallelic homologous recombination (NAHR) between region-specific low-copy repeats (LCRs). For other nonrecurrent rearrangements, nonhomologous end joining (NHEJ) is implicated. Pelizaeus-Merzbacher disease (PMD) is an X-linked dysmyelinating disorder caused most frequently (60%-70%) by nonrecurrent duplication of the dosage-sensitive proteolipid protein 1 (PLP1) gene but also by nonrecurrent deletion or point mutations. Many PLP1 duplication junctions are refractory to breakpoint sequence analysis, an observation inconsistent with a simple recombination mechanism. Our current analysis of junction sequences in PMD patients confirms the occurrence of simple tandem PLP1 duplications but also uncovers evidence for sequence complexity at some junctions. These data are consistent with a replication-based mechanism that we term FoSTeS, for replication Fork Stalling and Template Switching. We propose that complex duplication and deletion rearrangements associated with PMD, and potentially other nonrecurrent rearrangements, may be explained by this replication-based mechanism.
Comment in
-
Template switching: from replication fork repair to genome rearrangements.Cell. 2007 Dec 28;131(7):1228-30. doi: 10.1016/j.cell.2007.12.007. Cell. 2007. PMID: 18160033
Similar articles
-
Template switching: from replication fork repair to genome rearrangements.Cell. 2007 Dec 28;131(7):1228-30. doi: 10.1016/j.cell.2007.12.007. Cell. 2007. PMID: 18160033
-
Role of genomic architecture in PLP1 duplication causing Pelizaeus-Merzbacher disease.Hum Mol Genet. 2006 Jul 15;15(14):2250-65. doi: 10.1093/hmg/ddl150. Epub 2006 Jun 14. Hum Mol Genet. 2006. PMID: 16774974
-
The molecular and cellular defects underlying Pelizaeus-Merzbacher disease.Expert Rev Mol Med. 2008 May 19;10:e14. doi: 10.1017/S1462399408000677. Expert Rev Mol Med. 2008. PMID: 18485258 Review.
-
Heterogeneous duplications in patients with Pelizaeus-Merzbacher disease suggest a mechanism of coupled homologous and nonhomologous recombination.Am J Hum Genet. 2005 Dec;77(6):966-87. doi: 10.1086/498048. Epub 2005 Oct 19. Am J Hum Genet. 2005. PMID: 16380909 Free PMC article.
-
Pelizaeus-Merzbacher disease as a chromosomal disorder.Congenit Anom (Kyoto). 2013 Mar;53(1):3-8. doi: 10.1111/cga.12005. Congenit Anom (Kyoto). 2013. PMID: 23480352 Review.
Cited by
-
Epigenetic modulators provide a path to understanding disease and therapeutic opportunity.Genes Dev. 2024 Jul 19;38(11-12):473-503. doi: 10.1101/gad.351444.123. Genes Dev. 2024. PMID: 38914477 Free PMC article. Review.
-
Consanguinty and its impact on health and genome dynamic: An example from Tunisia.Tunis Med. 2024 May 5;102(5):256-265. doi: 10.62438/tunismed.v102i5.4787. Tunis Med. 2024. PMID: 38801282 Free PMC article. Review. French.
-
Characterization, biogenesis model, and current bioinformatics of human extrachromosomal circular DNA.Front Genet. 2024 Apr 29;15:1385150. doi: 10.3389/fgene.2024.1385150. eCollection 2024. Front Genet. 2024. PMID: 38746056 Free PMC article.
-
A Recql5 mutant facilitates complex CRISPR/Cas9-mediated chromosomal engineering in mouse zygotes.Genetics. 2024 Jun 5;227(2):iyae054. doi: 10.1093/genetics/iyae054. Genetics. 2024. PMID: 38577877 Free PMC article.
-
An Integrated Approach Including CRISPR/Cas9-Mediated Nanopore Sequencing, Mate Pair Sequencing, and Cytogenomic Methods to Characterize Complex Structural Rearrangements in Acute Myeloid Leukemia.Biomedicines. 2024 Mar 7;12(3):598. doi: 10.3390/biomedicines12030598. Biomedicines. 2024. PMID: 38540211 Free PMC article.
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Research Materials
